Sign Up to like & get
recommendations!
0
Published in 2019 at "British Journal of Pharmacology"
DOI: 10.1111/bph.14845
Abstract: CR4056 is a first‐in‐class imidazoline‐2 (I2) receptor ligand characterized by potent analgesic activity in different experimental animal models of pain. In a recent phase II clinical trial, CR4056 effectively reduced pain in patients with knee…
read more here.
Keywords:
cr4056 powerful;
translocation;
imidazoline receptor;
receptor ligand ... See more keywords